LSTA (STOCKS)
Lisata Therapeutics, Inc. Common Stock
$4.990000
-0.020000 (-0.40%)
Prev close: $5.010000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David J. Mazzo
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $45.07M
- Employees
- 26
- P/E (TTM)
- -2.61
- P/B (TTM)
- 2.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.49 | $-0.55 | +0.0557 | +10.21% |
|
Jun 2025 (Q2)
|
$-0.54 | $-0.66 | +0.1230 | +18.55% |
|
Mar 2025 (Q1)
|
$-0.55 | $-0.54 | -0.0094 | -1.74% |
|
Dec 2024 (Q4)
|
$-0.55 | $-0.78 | +0.2252 | +29.05% |
Financial Statements
| Revenues | $170.00K |
| Benefits Costs and Expenses | $17.72M |
| Costs And Expenses | $17.72M |
| Nonoperating Income/Loss | $661.00K |
| Operating Expenses | $18.38M |
| Depreciation and Amortization | $146.00K |
| Other Operating Expenses | $18.23M |
| Operating Income/Loss | -$18.21M |
| Income/Loss From Continuing Operations After Tax | -$16.59M |
| Income/Loss From Continuing Operations Before Tax | -$17.55M |
| Income/Loss From Equity Method Investments | $0.00 |
| Income Tax Expense/Benefit | -$962.00K |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | -$962.00K |
| Net Income/Loss | -$16.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$16.59M |
| Net Income/Loss Available To Common Stockholders, Basic | -$16.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.91 |
| Diluted Earnings Per Share | -$1.91 |
| Basic Average Shares | 8,687,000 |
| Diluted Average Shares | 8,687,000 |
| Assets | $17.74M |
| Current Assets | $17.70M |
| Noncurrent Assets | $41.00K |
| Fixed Assets | $18.00K |
| Intangible Assets | $400.00K |
| Liabilities | $3.14M |
| Current Liabilities | $3.07M |
| Accounts Payable | $1.02M |
| Wages | $812.00K |
| Other Current Liabilities | $1.24M |
| Noncurrent Liabilities | $72.00K |
| Equity | $14.60M |
| Equity Attributable To Noncontrolling Interest | -$254.00K |
| Equity Attributable To Parent | $14.86M |
| Liabilities And Equity | $17.74M |
| Net Cash Flow From Operating Activities | -$15.95M |
| Net Cash Flow From Operating Activities, Continuing | -$15.95M |
| Net Cash Flow From Investing Activities | $15.09M |
| Net Cash Flow From Investing Activities, Continuing | $15.09M |
| Net Cash Flow From Financing Activities | $599.00K |
| Net Cash Flow From Financing Activities, Continuing | $599.00K |
| Exchange Gains/Losses | $11.00K |
| Net Cash Flow | -$253.00K |
| Net Cash Flow, Continuing | -$264.00K |
| Comprehensive Income/Loss | -$16.54M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$16.54M |
| Other Comprehensive Income/Loss | $44.00K |